Publications by authors named "Intidhar Labidi-Galy"

Claim this Profile
C
CldU sensitizes reverse-mutated cells to PARP inhibitors.
Nawel Zouggari, Camilla Trugenberger, Valentine Du Bois, Wenwen Wang, Giacomo G Rossetti, Intidhar Labidi-Galy

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning and reversible suppression of CCR7 dendritic cells in perivascular tumor niches shape cancer immunity.
Beatrice Zitti, Florent Duval, Pratyaksha Wirapati, Mehdi Hicham, Yuxuan Xie, Sana Intidhar Labidi-Galy

Immunity· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial.
Marie-Estelle Gaignard, Dominica Martin, Jelena Stanic, Roger Hilfiker, Alexandre Bodmer, Intidhar Labidi-Galy

Psychooncology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series.
Thomas Westerhoff, Nathalie Baudoux, Manuela Undurraga, Patrick Petignat, Intidhar Labidi-Galy

Gynecol Oncol Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
Yann Christinat, Intidhar Labidi-Galy, Liza Ho, Sophie Clément, Catherine Genestie

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Rémy Pétremand, Johanna Chiffelle, Sara Bobisse, Marta A S Perez, Julien Schmidt, S Intidhar Labidi-Galy

Nat Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Rémy Pétremand, Johanna Chiffelle, Sara Bobisse, Marta A S Perez, Julien Schmidt, S Intidhar Labidi-Galy

Nat Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors.
Valeria Lombardi Fäh, Federico Del Vento, S Intidhar Labidi-Galy, Manuela Undurraga

Gynecol Oncol Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma.
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Intidhar Labidi-Galy

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix.
Marie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, Jean-Christophe Tille, Patrick Petignat, S Intidhar Labidi-Galy

Gynecol Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.
Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Dogan, Ewa Gogola, Intidhar Labidi-Galy

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Judith Balmaña, Peter A Fasching, Fergus J Couch, Suzette Delaloge, Intidhar Labidi-Galy

Breast Cancer Res Treat· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor.
José L Sandoval, S Intidhar Labidi-Galy

Oncogene· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
Ketty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, Chang Ming, Jean-Damien Combes, S Intidhar Labidi-Galy

Fam Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.
Teresa Zielli, Intidhar Labidi-Galy, Maria Del Grande, Cristiana Sessa, Ilaria Colombo

Cancer Drug Resist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape.
Maxime Borgeaud, Marie-Gabrielle Courtes, Petros Tsantoulis, Alexandre Bodmer, Intidhar Labidi-Galy

Praxis (Bern 1994)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.
Noémie Lang, Aurélie Ayme, Chang Ming, Jean-Damien Combes, Victor N Chappuis, S Intidhar Labidi-Galy

Swiss Med Wkly· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study ().
Julien Maillard, Nadia Elia, Frédéric Ris, Delphine S Courvoisier, Dina Zekry

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity.
Noemie Lang, Antonella Diciola, Intidhar Labidi-Galy, Frédéric Ris, Mariagrazia Di Marco

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Intraperitoneal therapy for carcinomatosis in ovarian cancer: proposed treatment algorithm].
Manuela Undurraga, Patrice Mathevet, Martin Hubner, Nicolas C Buchs, Maxime Warlaumont, Intidhar Labidi-Galy

Rev Med Suisse· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Intidhar Labidi-Galy

iScience· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Alfredo Addeo, Pankil K Shah, Natacha Bordry, Robert D Hudson, Brenna Albracht, Intidhar Labidi-Galy

Cancer Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
Karen A Gelmon, Peter A Fasching, Fergus J Couch, Judith Balmaña, Suzette Delaloge, Intidhar Labidi-Galy

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Timothée Olivier, Eugenio Fernandez, Intidhar Labidi-Galy, Pierre-Yves Dietrich, Veronica Rodriguez-Bravo

Cancer Treat Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.
Eleftherios P Samartzis, S Intidhar Labidi-Galy, Michele Moschetta, Mario Uccello, Dimitrios R Kalaitzopoulos

Ann Transl Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis